PRECIPIO, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
PRECIPIO, INC. (PRPO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $1.99 per share for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2020-11-13
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2020-03-31 was $2.09, a 7.11% decline year-over-year.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2019-03-31 was $2.25.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2015-03-31 was $2.01.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2013-03-31 was $0.57.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2012 was $1.01, a 13.68% decline from fiscal 2011.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2011 was $1.17, a 134.00% increase from fiscal 2010.
- PRECIPIO, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2010 was $0.50.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 0 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|---|
| 2020-09-30 | $1.99 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | $2.13 10-Q · filed 2020-08-13 | ||||
| 2020-03-31 | $2.09 10-Q · filed 2020-05-14 | ||||
| 2019-09-30 | $2.37 10-Q · filed 2019-11-13 | ||||
| 2019-06-30 | $2.37 10-Q · filed 2019-08-09 | ||||
| 2019-03-31 | $2.25 10-Q · filed 2019-05-16 | ||||
| 2018-09-30 | $0.70 10-Q · filed 2018-11-19 | ||||
| 2018-06-30 | $0.71 10-Q · filed 2018-08-16 | ||||
| 2015-09-30 | $1.51 10-Q · filed 2015-11-16 | ||||
| 2015-06-30 | $1.50 10-Q · filed 2015-08-14 | ||||
| 2015-03-31 | $2.01 10-Q · filed 2015-05-14 | ||||
| 2013-09-30 | $0.37 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $0.39 10-Q · filed 2013-08-08 | ||||
| 2013-03-31 | $0.57 10-Q · filed 2013-05-09 | ||||
| 2012-12-31 | $1.01 10-K · filed 2013-03-14 | ||||
| 2012-10-02 | $0.94 10-K · filed 2013-03-14 | ||||
| 2012-09-30 | $1.03 10-Q · filed 2012-11-08 | ||||
| 2012-09-12 | $0.98 10-K · filed 2013-03-14 | ||||
| 2012-07-02 | $0.86 10-K · filed 2013-03-14 | ||||
| 2012-06-30 | $1.36 10-Q · filed 2012-08-02 | ||||
| 2012-04-02 | $1.19 10-K · filed 2013-03-14 | ||||
| 2012-02-15 | $1.45 10-K · filed 2013-03-14 | ||||
| 2011-12-31 | $1.17 10-K · filed 2013-03-14 | ||||
| 2010-12-31 | $0.50 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |